Form D · Pharmaceuticals
Psy Therapeutics, Inc.
Boston, MA · CIK 0001788222
Offering snapshot reported Sep 12, 2025 · SEC filing
- Reported sold
- $6.76M Offering amount: $20.4M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Dec 23, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 12, 2025 | Amendment | $6,762,848 | No comparison | 23 | SEC filing |
| Aug 9, 2024 | Amendment | $5,847,848 | $1,875,733vs Aug 10, 2023 | 16 | SEC filing |
| Aug 10, 2023 | Amendment | $3,972,115 | $1,199,500vs Dec 28, 2021 | 10 | SEC filing |
| Dec 28, 2021 | Initial | $2,772,615 | No comparison | 6 | SEC filing |
| Oct 2, 2019 | Initial | $3,967,692 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-426963
Amount sold includes $1,772,615 of principal and accrued interest on certain prior convertible promissory notes which were converted to First Tranche Convertible Promissory Notes.
Source: Form D, filed Sep 12, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David S. Barlow | Director, Executive |
| Brant Binder | Director, Executive |
| Alan Cross | Director |
| Paul Murphy | Director |
| Bryan Roberts | Director |
| Jerry F. Rosenbaum | Director |
| Jeff Troderman | Executive |
| William Wagner | Executive |
| Daniel Weiss Pick | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
28 Atlantic Ave, Suite 222
Boston, MA, 02110
Phone: (617) 723-5429
Boston, MA, 02110
Phone: (617) 723-5429